Protara Therapeutics

+$0.07 (+2.23%) Today
+$0.06 (+1.87%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TARA and other ETFs, options, and stocks.

About TARA

Protara Therapeutics, Inc. is a clinical-stage company engaged in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders.

CEO
Jesse Shefferman
Employees
31
Headquarters
New York, New York
Founded
2006

TARA Key Statistics

Market cap
36.12M
Price-Earnings ratio
—
Dividend yield
—
Average volume
39.97K
High today
$3.38
Low today
$3.14
Open price
$3.17
Volume
23.82K
52 Week high
$11.10
52 Week low
$2.72

TARA Earnings

-$1.26
-$0.84
-$0.42
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure